176 related articles for article (PubMed ID: 7109463)
1. [Chemotherapy of purulent meningitis in childhood. I. Pharmacokinetics of antibacterial drugs in the cerebrospinal fluid].
Scherber A; Henker J
Kinderarztl Prax; 1982 Apr; 50(4):182-6. PubMed ID: 7109463
[No Abstract] [Full Text] [Related]
2. [Permeability of antibacterial drugs in the cerebrospinal fluid].
Meyer FP; Walther H
Z Arztl Fortbild (Jena); 1984; 78(17):703-10. PubMed ID: 6506776
[No Abstract] [Full Text] [Related]
3. [Chemotherapy of purulent meningitis in childhood. II. Special pharmacokinetics of the most commonly used chemotherapeutics in purulent meningitis].
Henker J; Scherber A
Kinderarztl Prax; 1982 Jun; 50(6):288-92. PubMed ID: 7132064
[No Abstract] [Full Text] [Related]
4. [Significance of monomycin concentration in the cerebrospinal fluid in the treatment of experimental purulent meningitis].
Mosiĭchuk NM
Zh Eksp Klin Med; 1969; 9(5):47-51. PubMed ID: 4913233
[No Abstract] [Full Text] [Related]
5. Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid.
Täuber MG; Sande MA
Scand J Infect Dis Suppl; 1990; 74():173-8. PubMed ID: 2097706
[TBL] [Abstract][Full Text] [Related]
6. [Antibiotics, particularly relating to treatment of purulent meningitis (author's transl)].
Kobayashi Y; Haruta T
No Shinkei Geka; 1981 Jun; 9(7):771-83. PubMed ID: 7022250
[No Abstract] [Full Text] [Related]
7. [Intrathecal use of antibiotics in childhood].
Nigro N
Minerva Pediatr; 1982 Feb; 34(3):135-6. PubMed ID: 6896228
[No Abstract] [Full Text] [Related]
8. Strategies and new developments in the management of bacterial meningitis.
Miranda J; Tunkel AR
Infect Dis Clin North Am; 2009 Dec; 23(4):925-43, viii-ix. PubMed ID: 19909891
[TBL] [Abstract][Full Text] [Related]
9. [Bacterial meningitis].
Di Nola F
Minerva Med; 1987 Jan; 78(1):1-19. PubMed ID: 3808396
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic therapy of purulent meningitis].
Sansonetti PJ; Dupont B
Ann Med Interne (Paris); 1986; 137(5):369-71. PubMed ID: 3813266
[No Abstract] [Full Text] [Related]
11. [Antibacterial activity of the cerebrospinal fluid during antibiotic therapy (50 cases of meningitis)].
Turcu T; Vâţă A; Grigoriu A; Cuciureanu G; Râpeanu E; Mihalache D; Danilă F
Rev Med Chir Soc Med Nat Iasi; 1977; 81(2):193-200. PubMed ID: 905675
[No Abstract] [Full Text] [Related]
12. [The blood-cerebrospinal fluid barrier].
Ferlazzo A
Pediatria (Napoli); 1982; 90(4):403-21. PubMed ID: 6763192
[No Abstract] [Full Text] [Related]
13. [Measurement of antibiotic activity in cerebrospinal fluid and treatment of purulent meningitis].
Raffi A; Véron M; Kasmierczak A; Canal JP; Lonchamp D; Noir A; Schirrer J
Arch Fr Pediatr; 1970 Apr; 27(4):437-8. PubMed ID: 5421702
[No Abstract] [Full Text] [Related]
14. The causes for low spinal fluid sugar in bacterial meningitis: another look.
Menkes JH
Pediatrics; 1969 Jul; 44(1):1-3. PubMed ID: 5795399
[No Abstract] [Full Text] [Related]
15. [Purulent meningitis in older children and adults (author's transl)].
Pohle HD
MMW Munch Med Wochenschr; 1980 Mar; 122(11):383-6. PubMed ID: 6768996
[TBL] [Abstract][Full Text] [Related]
16. [Diffusion of fosfomycin into the cerebrospinal fluid in purulent meningitis].
Stahl JP; Croize J; Bru JP; Girard-Blanc MF; François P; Gaillat J; Micoud M
Presse Med; 1984 Dec; 13(44):2693-5. PubMed ID: 6240034
[TBL] [Abstract][Full Text] [Related]
17. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)].
Modai J
Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071
[TBL] [Abstract][Full Text] [Related]
18. [Nonconjugated 11-hydroxycorticosteroid content of the cerebrospinal fluid and their permeability through the blood-brain barrier in children with purulent meningitis].
Titel'man KM; Kipnis SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1487-91. PubMed ID: 5490134
[No Abstract] [Full Text] [Related]
19. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis.
Nigrovic LE; Malley R; Macias CG; Kanegaye JT; Moro-Sutherland DM; Schremmer RD; Schwab SH; Agrawal D; Mansour KM; Bennett JE; Katsogridakis YL; Mohseni MM; Bulloch B; Steele DW; Kaplan RL; Herman MI; Bandyopadhyay S; Dayan P; Truong UT; Wang VJ; Bonsu BK; Chapman JL; Kuppermann N;
Pediatrics; 2008 Oct; 122(4):726-30. PubMed ID: 18829794
[TBL] [Abstract][Full Text] [Related]
20. [Permeability of the hemato-encephalic barrier to antibiotics in patients with infectious meningitis].
Mosiĭchuk NM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(3):338-42. PubMed ID: 4872691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
